XJPX
5194
Market cap42mUSD
Oct 09, Last price
614.00JPY
1D
-0.65%
1Q
-8.63%
Jan 2017
-32.23%
Name
Sagami Rubber Industries Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sagami Rubber Industries Co., Ltd. is principally involved in the manufacture and supply of condoms. The company's product line features polyurethane and latex-based condoms, alongside external catheters, probe covers, plastic films, and a variety of healthcare goods and services. Its merchandise is distributed across numerous global markets, including Japan, France, Switzerland, Italy, Portugal, Spain, Finland, Norway, Sweden, Korea, Vietnam, Mexico, and the United States. Founded in 1934, the firm's corporate headquarters are located in Atsugi, Japan.
Key people
Koichi Fukuda
Chief Director of Plastic Sales, Director of Plastic Business, Director · since 2010
Shinji Hara
Chief Director of Healthcare Business Sales, Director · since 2013
Takuji Ito
Director · since 2016
Ichiro Ohato
Chairman of the Board, Representative Director · since 2025
Kensuke Ohato
President, Representative Director · since 2025
Noriko Ohato
Director · since 2016
Shigeo Tadenuma
Director · since 2025
Makoto Wada
Director · since 2016
Kunio Yoshida
Senior Managing Director · since 2024
Tomoyuki Kanouchi
Independent Director · since 2025
Naoko Kuroishi
Independent Director · since 2025
Muneto Tamagami
Independent Director · since 2025
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||